title: Regulating the pharmaceutical industry. Australian scheme has disadvantages.
authors.forename: P R
authors.initials: PR
authors.lastname: Clear
authors.forename: M
authors.initials: M
authors.lastname: Grobler
mesh_terms: D001315:Australia; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D006113:United Kingdom